Correspondence 0001628280-23-013061 from LianBio (LIANY) (CIK 0001831283) (LIANY)
LianBio (LIANY) (CIK 0001831283)
Date: April 26, 2023 · CIK: 0001831283 · Accession: 0001628280-23-013061
AI Filing Summary & Sentiment
File numbers found in text: 333-268317
Show Raw Text
CORRESP 1 filename1.htm Document LIANBIO 103 Carnegie Center Drive, Suite 309 Princeton, NJ 08540 April 26, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Jimmy McNamara Joe McCann Re: LianBio Registration Statement on Form S-3 (File No. 333-268317) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, LianBio, an exempted company organized under the Laws of the Cayman Islands (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on April 27, 2023, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, LIANBIO By: /s/ Yizhe Wang Name: Yizhe Wang, Ph.D. Title: Chief Executive Officer Signature Page to Acceleration Request